Polypeptide-Induced Polymerization for Enhanced Extracellular Vesicle Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing extracellular vesicles (EVs) are inefficient, requiring time-consuming differential ultracentrifugation and resulting in low yields, making it challenging to mass-produce EVs for therapeutic applications.
Innovation Solution
A method involving the treatment of cells with a purified polypeptide precursor, such as NapFFK(NDB)Yp, which polymerizes within cells due to enzymes like phosphatase, leading to enhanced EV production. The polypeptide is added at concentrations between 5 μM and 50 μM, and the polymerization process is allowed to occur for 20-60 minutes, resulting in increased EV yields.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If differential ultracentrifugation is used for EV isolation, then EVs can be isolated and analyzed, but the process is time-consuming (4-5 hours) and yields are low (5-25% recovery)
Solution Approach 1:
The patent changes the chemical parameters of the cell culture medium by adding specific compounds (such as PEG, lipids, or small molecules) that modify the physical-chemical environment to stimulate EV release. This parameter change in the culture conditions directly increases EV production yield without requiring time-consuming ultracentrifugation procedures.
Solution Approach 2:
The patent introduces intermediary substances (chemical compounds or growth factors) that mediate between the cell culture system and EV production. These intermediaries act as signaling molecules or structural modifiers that enhance EV release and can be easily removed or remain in the culture medium, avoiding the need for complex isolation procedures.
2Quantity of substance
If conventional EV isolation methods are used, then EVs can be obtained, but the yield is too low (5-25% recovery) for most downstream analysis and therapeutics
Solution Approach 1:
The patent performs preliminary actions by pre-treating the cell culture with specific compounds or growth factors before EV harvest. This preliminary treatment primes the cells to release higher quantities of EVs, ensuring sufficient yield for downstream applications without requiring intensive isolation procedures afterward.
Solution Approach 2:
The patent modifies cultural parameters such as pH, temperature, or chemical composition of the medium to optimize EV release. By changing these parameters, the system achieves higher EV yields that meet the requirements for downstream analysis and therapeutic applications.
3Adaptability or versatility
If EVs are produced for therapeutic applications, then they can serve as off-the-shelf therapeutics, but mass production is the bottleneck
Solution Approach 1:
The patent develops a universal method that can be applied to multiple cell types and EV applications. The chemical treatment protocol is broadly applicable across different cell lines and therapeutic contexts, enabling mass production of EVs for various therapeutic uses while maintaining the off-the-shelf versatility required for clinical applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly enhances EV production by increasing the number of EVs released from cells by at least 50% compared to untreated cells, while maintaining consistent EV sizes, and allows for stable labeling of EVs with fluorescent tags, making them suitable for long-term circulation studies.
Implementation Method 1
the NapFFK(NDB)Yp to polymerize within cells in the plurality of cells due to an enzyme within the cells
Data Source
AI summary
A method for enhancing extracellular vesicle production is described. A peptide that induces polymer formation is incubated with a cell culture which results in enhanced EV production. The peptide penetrates the cells and subsequently polymerizes upon exposure to enzymes (e.g. phosphatase) within the cell. The cells that contain the newly formed polymers have an increased production of EVs. These EVs can be harvested using centrifugation techniques.